Retraction notice to “Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systemativ review and meta-analysis” [Curr. Res. Pharmacol. Drug Discov. 4C (2023) 100140]

Affiliations

Anthéa Bertrand: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France
Denis Gallot: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Equipe, “Translationnal Approach to Epithelial Injury and Repair”, Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000, Clermont-Ferrand, France
Bruno Pereira: CHU Clermont-Ferrand, Biostatistics Unit (DRCI) Department, Clermont-ferrand, France
Amélie Delabaere: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000, Clermont-Ferrand, France; Corresponding author.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal).

ISSN: 2590-2571 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://www.journals.elsevier.com/current-research-in-pharmacology-and-drug-discovery/